Recursion Pharmaceuticals Inc. (RXRX)
Market Closed
22 Apr, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 62
+0.21
+3.97%
$
1.72B Market Cap
- P/E Ratio
0% Div Yield
13,799,833 Volume
-1.72 Eps
$ 5.41
Previous Close Day Range
5.46 5.7
Year Range
3.79 12.36
Earnings results expected in 14 days
Want to track RXRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| RXRX Recursion Pharmaceuticals Inc. 7 May 2025 (14 Days) | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 25 Feb 2025 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 7 Nov 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 6 Nov 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 8 Aug 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 6 Aug 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 3 Jun 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 20 May 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 6 May 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 27 Feb 2024 | | - Cons. EPS | - EPS |
2025 © Marketlog. All Rights Reserved.
